ArticleBMC cancer2020

Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel.

Hakon Blomstrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.